It will be of interest to determine the effects of genetic perturbation of BPTF, TCP11L1 and LDB1 on HD and assess whether these interventions would be useful therapeutic approaches, thus reconciling differences in transcriptomic and proteomic data. The gene discussed is BPTF; the disease is Huntington disease.